Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 26.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 82,611 shares of the company’s stock after buying an additional 17,485 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Colgate-Palmolive were worth $6,480,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of the business. Westside Investment Management Inc. lifted its stake in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the period. Vermillion & White Wealth Management Group LLC grew its stake in shares of Colgate-Palmolive by 86.1% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after purchasing an additional 155 shares during the period. MTM Investment Management LLC bought a new stake in Colgate-Palmolive in the second quarter valued at about $39,000. Atticus Wealth Management LLC boosted its holdings in Colgate-Palmolive by 156.8% during the second quarter. Atticus Wealth Management LLC now owns 488 shares of the company’s stock worth $44,000 after buying an additional 298 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth about $44,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Ratings Changes
CL has been the topic of a number of analyst reports. Piper Sandler set a $88.00 price target on shares of Colgate-Palmolive and gave the company an “overweight” rating in a research report on Tuesday, January 6th. Jefferies Financial Group set a $85.00 price objective on Colgate-Palmolive in a research note on Tuesday, December 16th. JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $87.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, December 18th. Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Finally, UBS Group lowered their target price on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Eleven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $88.19.
Colgate-Palmolive Price Performance
NYSE CL opened at $81.44 on Monday. The firm’s 50 day moving average is $78.71 and its 200-day moving average is $81.91. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The company has a market capitalization of $65.64 billion, a PE ratio of 22.81, a price-to-earnings-growth ratio of 5.52 and a beta of 0.30. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same quarter last year, the firm earned $0.91 earnings per share. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. Equities research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s payout ratio is currently 58.26%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Do not delete, read immediately
- Trump Planning to Use Public Law 63-43: Prepare Now
- Huge robotics rollout underway
- How a Family Trust May Be Able To Help Preserve Your Wealth
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
